By Tony Fong

NEW YORK (GenomeWeb News) – The number of mergers and acquisitions in the life science 'omics tools and molecular diagnostics space rose 15 percent year over year for the first half of 2011, spurred on by the low cost of debt and a handful of companies that proved to be especially aggressive buyers.

Despite the uptick, though, the M&A environment remains mixed and the forecast for the near future is unclear, according to industry observers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.